Topology and saddle points in field theories

por Forgács, Péter, Horváth, Z
Publicado 1984

Workshop and Conference on Nonperturbative Methods in Quantum Field Theory

por Horváth, Z, Palla, László, Patkós, András
Publicado 1987

Workshop and Conference on Frontiers in Nonperturbative Field Theory

por Horváth, Z, Palla, László, Patkós, András
Publicado 1988

On the construction of axially symmetric SU(N) monopoles

por Forgács, Péter, Horváth, Z, Palla, L
Publicado 1982

Solution-generating technique for self-dual monopoles

por Forgács, Péter, Horváth, Z, Palla, L
Publicado 1983

Stable compactifying Einstein-Yang-Mills systems

por Forgács, Péter, Horváth, Z, Palla, L
Publicado 1984

17th Johns Hopkins Workshop on Current Problems in Particle Theory

por Horváth, Z, Palla, László, Patkós, András
Publicado 1994

Classical solutions of CP$^{N-1}$ models in 2 + 1 dimensions

por Forgács, Péter, Zakrzewski, W J, Horváth, Z
Publicado 1984

14th Johns Hopkins Workshop on Current Problems in Particle Theory

por Domokos, Gabor K, Horváth, Z, Kövesi-Domokos, S
Publicado 1991

A database for exact solutions in general relativity

por Horváth, I L, Horváth, Z, Lukács, B
Publicado 1993

CBT-based psychological rehabilitation program for oncological patients

por Juhász, A., Horváth, Z., Szekeres, T., Vizin, G.
Publicado 2022

The mediating role of state shame, guilt, and pride in the relationship between self-compassion and prolonged grief

por Szőcs, H., Sandheden, L., Horváth, Z., Vizin, G.
Publicado 2022

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer

por Schmid, K, Bago-Horvath, Z, Berger, W, Haitel, A, Cejka, D, Werzowa, J, Filipits, M, Herberger, B, Hayden, H, Sieghart, W
Publicado 2010

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry

por Singer, C.F., Jahn, S.W., Rudas, M., Bago-Horvath, Z., Fitzal, F., Abete, L., Moinfar, F., Gnant, M., Filipits, M.
Publicado 2022

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival

por Wimmer, K., Bolliger, M., Bago-Horvath, Z., Steger, G., Kauer-Dorner, D., Helfgott, R., Gruber, C., Moinfar, F., Mittlböck, M., Fitzal, F.
Publicado 2019

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

por Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Publicado 2014

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

por Zagouri, F, Bago-Horvath, Z, Rössler, F, Brandstetter, A, Bartsch, R, Papadimitriou, C A, Dimitrakakis, C, Tsigginou, A, Papaspyrou, I, Giannos, A, Dimopoulos, M-A, Filipits, M
Publicado 2013

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

por Berghoff, A S, Bago-Horvath, Z, Ilhan-Mutlu, A, Magerle, M, Dieckmann, K, Marosi, C, Birner, P, Widhalm, G, Steger, G G, Zielinski, C C, Bartsch, R, Preusser, M
Publicado 2012

Prognostic impact of breast cancer subtypes in elderly patients

por Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Publicado 2016

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

por Bartsch, R, Berghoff, A, Pluschnig, U, Bago-Horvath, Z, Dubsky, P, Rottenfusser, A, DeVries, C, Rudas, M, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G
Publicado 2012